Proteome changes during in vitro culture adaptation of Toxoplasma gondii archetypal II and III field isolates
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1633384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Joachim Müller und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Toxoplasma, Proteome, Protozoan Proteins, Adaptation, Physiological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Rapid in vitro culture adaptation of recently obtained Toxoplasma gondii isolates leading to deep changes in relevant phenotypic traits has been demonstrated earlier. Few reports exist on the molecular bases that govern this adaptation. Herein, we analyzed the T. gondii proteomes of different isolates at two timepoints during cell culture adaptation.
Methods
The differential proteomes of six recently obtained archetypal European T. gondii Type II (TgShSp1 (Genotype ToxoDB#3), TgShSp2 (#1), TgShSp3 (#3) and TgShSp16 (#3)) and Type III (TgShSp24 (#2) and TgPigSp1(#2)) isolates maintained at low (10-16) and high (50-53) passage numbers in Vero cells were determined by label free liquid chromatography–mass spectrometry.
Results
Among these isolates, 2.3% and 10.2% of proteins were differentially or constantly abundant when comparing low and high passage numbers. Constant proteins included components involved in essential cellular processes such as energy metabolism or protein synthesis, many of them identified as drug and vaccine targets. Interestingly, differentially abundant proteins were clearly linked to phenotypic changes associated to in vitro adaptation: loss of ability to spontaneously form cysts at high passages and decreased expression of cyst and bradyzoite markers (BAG1, Enolase 1, and SRS35A), while culture adaptation was associated with increased abundance of recognized virulence factors such as GRA15, GRA16, TEEGR and NSM.
Conclusion
Our results highlight the changes at the proteomic level that take place in recently obtained isolates after in vitro culture adaptation, an important feature that should be considered during T. gondii investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Parasitology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
- SALUVET-INNOVA, Animal Health Department, Faculty of Veterinary Sciences, Complutense University of Madrid, Madrid, Spain.
- SALUVET, Animal Health Department, Faculty of Veterinary Sciences, Complutense University of Madrid, Madrid, Spain.
- Proteomics and Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.
Zitieren
APA
Müller, J., Regidor-Cerrillo, J., Arranz-Solís, D., Braga-Lagache, S., Uldry, A. C., Heller, M., Calero-Bernal, R., Hemphill, A., & Ortega-Mora, L. M. (2025). Proteome changes during in vitro culture adaptation of Toxoplasma gondii archetypal II and III field isolates. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1633384
Vancouver
Müller J, Regidor-Cerrillo J, Arranz-Solís D, Braga-Lagache S, Uldry AC, Heller M, et al. Proteome changes during in vitro culture adaptation of Toxoplasma gondii archetypal II and III field isolates. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1633384
BibTeX
@article{Mller2025,
author = {Müller, Joachim and Regidor-Cerrillo, Javier and Arranz-Solís, David and Braga-Lagache, Sophie and Uldry, Anne-Christine and Heller, Manfred and Calero-Bernal, Rafael and Hemphill, Andrew and Ortega-Mora, Luis Miguel},
title = {Proteome changes during in vitro culture adaptation of Toxoplasma gondii archetypal II and III field isolates},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1633384}
}
EUVIMED